N-Acetyl Cysteine · N-Acetyl-L-Cysteine
N-Acetyl Cysteine (NAC) is an acetylated derivative of the conditionally essential amino acid L-cysteine. It serves as a direct precursor to glutathione (GSH) - the body's primary intracellular antioxidant. By providing the rate-limiting substrate for glutathione synthesis, NAC indirectly elevates reduced glutathione levels across tissues, including the liver, brain, and lung.
Starting dose. 600mg — 1-2x daily
Can be taken with or without food; better absorbed on empty stomach but GI tolerance improves with food. Split dosing recommended for doses >1,200mg/day. For mucolytic effect, take 600-1,200mg morning + evening.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
NAC deacetylates in the intestine and liver to release L-cysteine, the rate-limiting amino acid for glutathione (GSH) biosynthesis. Glutathione is the body's master antioxidant, present in millimolar concentrations intracellularly, and directly neutralizes reactive oxygen species, detoxifies xenobiotics via glutathione-S-transferases, and maintains protein thiol redox state.
NAC directly reduces disulfide bonds in mucoproteins, breaking up thick mucus and providing its mucolytic effect in respiratory conditions. NAC also scavenges free radicals directly via its thiol group, independent of GSH synthesis.
In the brain, NAC modulates the glutamate system by restoring extracellular glutamate homeostasis via the cystine-glutamate antiporter (xCT). Elevated cystine exchange drives glutamate into synaptic clefts, activating metabotropic glutamate receptors and normalizing pathologically elevated or depressed glutamate transmission. This underlies its use in OCD, addiction, trichotillomania, and depression.
NAC also downregulates NF-kB signaling, reducing inflammatory cytokine production. In the liver, it binds reactive metabolites of acetaminophen (NAPQI), preventing hepatotoxicity - the basis for its FDA-approved emergency use.
Weeks 1-2: Sulfur odor adaptation, respiratory mucolytic effect noticeable if present.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
Evidence boundary from the checked abstract: N-acetylcysteine (NAC) is an effective pleiotropic drug with a strong safety profile.
N-acetylcysteine (NAC) is an effective pleiotropic drug with a strong safety profile.
Evidence scope. This entry supports only the exact statement quoted from the live abstract; it does not independently verify OnePin's displayed dose, route, frequency, formulation, population, or broader mechanism.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 600mg 1-2x daily; Oral; 1-3x daily with or between meals. No checked live PubMed abstract verified this exact displayed dose, route, and frequency for the same molecule/formulation and relevant population.
Primary safety claim: Rotten egg sulfur odor and taste (reduced by capsule/enteric-coated forms). No checked live PubMed abstract directly verified this source-JSON safety claim at the displayed formulation, route, and regimen.
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
Plasma (acetylated form); intracellular cysteine and glutathione elevation persists longer (~12-24 hours).
Oral; ~30 min IV.
For most systemic effects; tissue glutathione levels restored over days-weeks of chronic dosing.
Oral (extensive first-pass metabolism). Despite low bioavailability, clinical effects are reliably reproducible suggesting active hepatic first-pass effect contributes.
Acute mucolytic/antioxidant effects: 6-12 hours. Chronic GSH elevation: persists 2-3 days after last dose. Mental health effects (OCD, depression) require 8-12 weeks of consistent dosing to manifest.
Hepatic deacetylation to cysteine, which enters glutathione synthesis or other cysteine-dependent pathways. Renal excretion of minor metabolites.
Storage. Store at room temperature (15-30C) in a cool, dry place. Protect from moisture. Capsules shelf-stable 2+ years. Some sulfur odor is normal and does not indicate degradation.
Has dual status: FDA-approved prescription drug (Mucomyst, Acetadote) for mucolytic and acetaminophen overdose indications. Also widely sold as dietary supplement. FDA issued 2020 warning letters questioning supplement status, but enforcement discretion continues to allow OTC sales. Status remains ambiguous.
Put it to work
Open NAC (N-Acetyl Cysteine) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open NAC (N-Acetyl Cysteine) in the app →Go deeper
The complete NAC (N-Acetyl Cysteine) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.